The document is a regulatory intimation regarding the availability of an audio recording for an earnings conference call.
The event type was an Earnings Conference Call for Q2 FY 2026-27 Results.
The call was held on Friday, November 06, 2026.
The stated purpose of the event was to discuss the company's Q2 FY27 results.
The disclosure is made in continuation of an earlier letter dated November 02, 2026.
The audio recording of the conference call has been made available on the company's website at: https://ikshealth.com/ir/2027/q2/q2-earnings-call-recording.mp3
The filing is made pursuant to Regulation 30 and 46(2)(oa) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.
The signatory is Sameer S Chavan, Company Secretary and Compliance Officer (Membership No. F7211).
Additional Notes Section
The document is a formal letter addressed to The Listing Departments of both BSE Limited and the National Stock Exchange of India Limited.
No financial data, guidance references, or presentation summaries were disclosed in this specific announcement.
The document serves purely as a compliance intimation regarding the availability of the recorded call.
No management participants or their designations were listed in this disclosure.
